ANA MIRICA: Open Payments
NPI 1346507803 · WESTMONT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$930 in 40 payments from 14 companies in 2025. Trend: 2023 $84 · 2024 $597 · 2025 $930
Food & beverage: $930
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $266 |
| Axsome Therapeutics, Inc. | 3 | $151 |
| Neos Therapeutics, LP | 6 | $119 |
| Noven Therapeutics, LLC | 3 | $68 |
| Supernus Pharmaceuticals, Inc. | 3 | $60 |
| Lundbeck LLC | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Tris Pharma Inc | 2 | $34 |
| Almatica Pharma LLC | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
Products named: VRAYLAR, Auvelity, Adzenys XR-ODT, REXULTI, Qelbree, Secuado, CAPLYTA, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
